Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Newfield Exploration stock logo
NFX
Newfield Exploration
$17.07
$0.00
$12.45
$31.46
$3.43B1.858.80 million shsN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
C$0.02
-25.0%
C$0.02
C$0.02
C$0.10
C$984K1.5152,289 shs4,000 shs
Valaris Limited stock logo
VAL
Valaris
$68.42
+0.9%
$69.58
$54.13
$78.92
$4.95B1.13863,714 shs92,133 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Newfield Exploration stock logo
NFX
Newfield Exploration
0.00%0.00%0.00%0.00%0.00%
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
0.00%0.00%0.00%0.00%0.00%
Valaris Limited stock logo
VAL
Valaris
+0.41%+1.04%-5.86%-1.41%+15.47%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
3.5521 of 5 stars
3.51.00.00.03.31.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
3.00
Buy$100.0046.16% Upside

Current Analyst Ratings

Latest PAS, VAL, NFX, and RLM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/5/2024
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$105.00 ➝ $102.00
2/23/2024
Valaris Limited stock logo
VAL
Valaris
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$107.00 ➝ $105.00
2/14/2024
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$106.00 ➝ $105.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Newfield Exploration stock logo
NFX
Newfield Exploration
$1.77B1.94$4.50 per share3.79$7.05 per share2.42
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AC$0.00 per share55.00C($0.02) per shareN/A
Valaris Limited stock logo
VAL
Valaris
$1.78B2.78$2.56 per share26.72$27.40 per share2.50

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Newfield Exploration stock logo
NFX
Newfield Exploration
$427M$2.157.945.170.3721.14%43.65%13.21%N/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/A-C$0.01N/AN/AN/AN/A-340.40%N/A
Valaris Limited stock logo
VAL
Valaris
$865.40M$11.695.856.59N/A48.50%5.71%2.40%5/2/2024 (Confirmed)

Latest PAS, VAL, NFX, and RLM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Valaris Limited stock logo
VAL
Valaris
$0.40N/A-$0.40N/AN/AN/A  
2/21/2024Q4 2023
Valaris Limited stock logo
VAL
Valaris
$0.29$0.61+$0.32-$10.08$484.00 million$483.80 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Newfield Exploration stock logo
NFX
Newfield Exploration
N/AN/AN/AN/AN/A
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Newfield Exploration stock logo
NFX
Newfield Exploration
1.30
0.72
0.70
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
882.79
0.03
0.17
Valaris Limited stock logo
VAL
Valaris
0.54
1.71
1.71

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Newfield Exploration stock logo
NFX
Newfield Exploration
97.87%
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
N/A
Valaris Limited stock logo
VAL
Valaris
96.74%

Insider Ownership

CompanyInsider Ownership
Newfield Exploration stock logo
NFX
Newfield Exploration
0.59%
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
15.43%
Valaris Limited stock logo
VAL
Valaris
0.11%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Newfield Exploration stock logo
NFX
Newfield Exploration
N/A200.93 millionN/AOptionable
Pascal Biosciences Inc. stock logo
PAS
Pascal Biosciences
665.59 millionN/ANot Optionable
Valaris Limited stock logo
VAL
Valaris
5,98572.41 million72.33 millionOptionable

PAS, VAL, NFX, and RLM Headlines

SourceHeadline
Valaris Limited (NYSE:VAL) Given Consensus Recommendation of "Buy" by AnalystsValaris Limited (NYSE:VAL) Given Consensus Recommendation of "Buy" by Analysts
americanbankingnews.com - April 26 at 3:08 AM
Valaris (NYSE:VAL) Upgraded by StockNews.com to "Sell"Valaris (NYSE:VAL) Upgraded by StockNews.com to "Sell"
americanbankingnews.com - April 26 at 2:18 AM
Equinor rolls up its sleeves for imminent Argentina exploration wellEquinor rolls up its sleeves for imminent Argentina exploration well
upstreamonline.com - April 25 at 9:14 AM
Valaris (VAL) Set to Announce Quarterly Earnings on ThursdayValaris (VAL) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - April 25 at 2:32 AM
Louisiana State Employees Retirement System Takes $1.21 Million Position in Valaris Limited (NYSE:VAL)Louisiana State Employees Retirement System Takes $1.21 Million Position in Valaris Limited (NYSE:VAL)
marketbeat.com - April 23 at 4:51 AM
John Fredriksen ally wins seat on board of potential takeover target International SeawaysJohn Fredriksen ally wins seat on board of potential takeover target International Seaways
tradewindsnews.com - April 18 at 10:48 PM
Valaris Limited (NYSE:VAL) Shares Sold by River Road Asset Management LLCValaris Limited (NYSE:VAL) Shares Sold by River Road Asset Management LLC
marketbeat.com - April 18 at 9:34 AM
Interocean announces UT technology demonstrationInterocean announces UT technology demonstration
zawya.com - April 16 at 8:33 AM
Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL)Mutual of America Capital Management LLC Acquires 38,367 Shares of Valaris Limited (NYSE:VAL)
marketbeat.com - April 14 at 6:11 AM
Valaris Schedules First Quarter 2024 Earnings Release and Conference CallValaris Schedules First Quarter 2024 Earnings Release and Conference Call
businesswire.com - April 11 at 4:30 PM
Aramco Suspends Valaris Rig ContractAramco Suspends Valaris Rig Contract
rigzone.com - April 11 at 1:38 AM
Valaris (VAL) Receives Rigs Suspension Notice From AramcoValaris (VAL) Receives Rig's Suspension Notice From Aramco
zacks.com - April 9 at 2:26 PM
Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL)Lancaster Investment Management Buys Shares of 400,116 Valaris Limited (NYSE:VAL)
marketbeat.com - April 9 at 12:12 PM
Port Everglades marks commissioning of new container cranesPort Everglades marks commissioning of new container cranes
en.portnews.ru - April 7 at 11:30 AM
Valaris faces rig suspension in Saudi joint ventureValaris faces rig suspension in Saudi joint venture
investing.com - April 6 at 2:41 AM
Aramco Suspends Another Jack-Up RigAramco Suspends Another Jack-Up Rig
oedigital.com - April 5 at 4:40 PM
Suspension notice for Valaris joint ventureSuspension notice for Valaris joint venture
royalgazette.com - April 5 at 4:40 PM
Saudi Aramco suspends offshore rig deal with New York-listed playerSaudi Aramco suspends offshore rig deal with New York-listed player
upstreamonline.com - April 5 at 1:44 AM
Aramco suspends jackup contract with offshore drillerAramco suspends jackup contract with offshore driller
upstreamonline.com - April 4 at 8:43 PM
Valaris (NYSE:VAL) Shares Gap Down to $76.66Valaris (NYSE:VAL) Shares Gap Down to $76.66
marketbeat.com - April 4 at 2:02 PM
Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc.Valaris Limited (NYSE:VAL) Shares Purchased by Vanguard Group Inc.
marketbeat.com - April 3 at 4:09 AM
Valaris: Buy Despite Near-Term Jackup Market HeadwindsValaris: Buy Despite Near-Term Jackup Market Headwinds
seekingalpha.com - April 2 at 7:31 PM
VAL Quantitative Stock AnalysisVAL Quantitative Stock Analysis
nasdaq.com - April 1 at 6:26 PM
Valaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from AnalystsValaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Buy" from Analysts
marketbeat.com - April 1 at 4:14 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Newfield Exploration logo

Newfield Exploration

NYSE:NFX
Newfield Exploration Company, an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids in the United States. The company has operations principally in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota, and the Uinta Basin of Utah. It also holds oil producing assets offshore China. The company was founded in 1988 and is headquartered in The Woodlands, Texas.
Pascal Biosciences logo

Pascal Biosciences

CVE:PAS
Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.
Valaris logo

Valaris

NYSE:VAL
Valaris Limited, together with its subsidiaries, provides offshore contract drilling services Gulf of Mexico, South America, North Sea, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Floaters, Jackups, ARO, and Other. It owns an offshore drilling rig fleet, which include drillships, dynamically positioned semisubmersible rigs, moored semisubmersible rig, and jackup rigs. It serves international, government-owned, and independent oil and gas. Valaris Limited was founded in 1975 and is based in Hamilton, Bermuda.